QuickLinks -- Click here to rapidly navigate through this document

Issuer Free Writing Prospectus
Filed Pursuant to Rule 433
Registration No. 333-226014
July 23, 2018


Pinduoduo Inc.

Pinduoduo Inc., or the Company, has filed a registration statement on Form F-1 (including a prospectus) with the Securities and Exchange Commission, or the SEC, for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus in that registration statement and other documents the Company has filed with the SEC for more complete information about the Company and this offering. Investors should rely upon the prospectus and any relevant free writing prospectus for complete details. You may obtain these documents and other documents the Company has filed for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the Company, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Credit Suisse Securities (USA) LLC at 1-800-221-1037, Goldman Sachs (Asia) L.L.C. at 852-2978-1000, China International Capital Corporation Hong Kong Securities Limited at 1-646-794-8800, and China Renaissance Securities (Hong Kong) Limited at 852-2287-1600. You may also access the Company's most recent prospectus dated July 23, 2018, which is included in Amendment No. 2 to the Company's registration statement on Form F-1, as filed with the SEC on July 23, 2018, or Amendment No. 2, by visiting EDGAR on the SEC website at: https://www.sec.gov/Archives/edgar/data/1737806/000104746918005119/a2236253zf-1a.htm

This free writing prospectus reflects the following amendments that were made in Amendment No. 2. All references to page numbers are to page numbers in Amendment No. 2.

Prospectus Summary

(1)
Amend the last sentence of the second paragraph on page 4 as follows:
(2)
Amend the last sentence of the fourth paragraph on page 4 as follows:
(3)
Amend the last sentence of the fifth paragraph on page 4 as follows:
(4)
Add the following at the end of "Ordinary shares outstanding immediately after this offering" on page 11:

1


(5)
Add the following on page 13:
Conflict of Interest   China Renaissance Securities (Hong Kong) Limited is an underwriter in this offering. China Renaissance Securities (Hong Kong) Limited is a wholly-owned subsidiary of China Renaissance Holdings Limited, which shares a common director with us, and as such may be deemed to be under common control with us and have a deemed "conflict of interest" within the meaning of Rule 5121 of the Financial Industry Regulatory Authority, Inc. Accordingly, this offering will be made in compliance with the applicable provisions of Rule 5121, which requires that a "qualified independent underwriter" meeting certain standards participate in the preparation of the registration statement and prospectus and exercise the usual standards of due diligence with respect thereto. Credit Suisse Securities (USA) LLC, Goldman Sachs (Asia) L.L.C. and China International Capital Corporation Hong Kong Securities Limited, and/or one of their SEC-registered broker-dealer affiliates, have agreed to act as "qualified independent underwriters" within the meaning of Rule 5121 in connection with this offering.

Risk Factors

(6)
Amend the second sentence of the risk factor under the heading "Risk Factors—Our limited operating history makes it difficult to evaluate our business and prospects. We cannot guarantee that we will be able to maintain the growth rate that we have experienced to date." on page 17 as follows:
(7)
Amend the second sentence of the risk factor under the heading "Risk Factors—We may incur liability for counterfeit, unauthorized, illegal, or infringing products sold or misleading information available on our platforms." on page 22 as follows:
(8)
Amend the risk factor under the heading "Risk Factors—We have granted and may continue to grant options and other types of awards under our share incentive plan, which may result in increased share-based compensation expenses." on page 34 as follows:

2


3


Capitalization

(9)
Amend the table and footnotes 1 and 2 to the table on page 67 as follows:
 
  As of March 31, 2018  
 
  Actual   Pro Forma   Pro Forma
As Adjusted(1)
 
 
  (in thousands)
 
 
  RMB
  US$
  RMB
  US$
  RMB
  US$
 

Mezzanine equity:

                                     

Series A1 convertible preferred shares (US$0.000005 par value; 71,849,380 shares authorized, issued and outstanding as of March 31, 2018)

    28,817     4,594                  

Series A2 convertible preferred shares (US$0.000005 par value; 238,419,800 shares authorized, issued and outstanding as of March 31, 2018)

    104,718     16,695                  

Series B1 convertible preferred shares (US$0.000005 par value; 211,588,720 shares authorized, issued and outstanding as of March 31, 2018)

    219,448     34,985                  

Series B2 convertible preferred shares (US$0.000005 par value; 27,781,280 shares authorized, issued and outstanding as of March 31, 2018)

    29,451     4,695                  

Series B3 convertible preferred shares (US$0.000005 par value; 145,978,540 shares authorized, issued and outstanding as of March 31, 2018)

    153,009     24,393                  

Series B4 convertible preferred shares (US$0.000005 par value; 292,414,780 shares authorized, issued and outstanding as of March 31, 2018)

    327,786     52,257                  

Series C1 convertible preferred shares, net of subscription receivable of RMB13,758 (US$2,000) as of December 31, 2017 (US$0.000005 par value; 56,430,180 shares authorized, issued and outstanding as of March 31, 2018)

    96,052     15,313                  

Series C2 convertible preferred shares (US$0.000005 par value; 238,260,780 shares authorized, issued and outstanding as of March 31, 2018)

    638,863     101,850                  

Series C3 convertible preferred shares (US$0.000005 par value; 241,604,260 shares authorized, issued and outstanding as of March 31, 2018)

    679,273     108,292                  

Series D convertible preferred shares (US$0.000005 par value; 551,174,340 shares authorized, issued and outstanding as of March 31, 2018)

    8,673,088     1,382,693                  

Total mezzanine equity

    10,950,505     1,745,767                  

Shareholders' deficits:

                                     

Class A ordinary shares (US$0.000005 par value; 6,208,214,480 shares authorized; 42,486,360 issued and outstanding on actual basis; 2,014,297,680 issued and outstanding on a pro forma basis; 2,356,697,680 issued and outstanding on a pro forma as adjusted basis)

    1         63     10     74     12  

Class B ordinary shares (US$0.000005 par value; 1,716,283,460 shares authorized; 1,716,283,460 issued and outstanding on actual basis; 1,819,974,200 shares issued and outstanding on a pro forma basis; 2,074,447,700 shares issued and outstanding on a pro forma as adjusted basis)

    53     8     56     9     64     10  

Additional paid-in capital(2)

    74,936     11,947     11,025,376     1,757,703     25,763,235     4,107,266  

Accumulated other comprehensive loss

    (121,176 )   (19,318 )   (121,176 )   (19,318 )   (121,176 )   (19,318 )

Accumulated deficits

    (1,311,754 )   (209,124 )   (1,311,754 )   (209,124 )   (6,952,959 )   (1,108,466 )

Total shareholders' (deficits)/equity(2)

    (1,357,940 )   (216,487 )   9,592,565     1,529,280     18,689,238     2,979,504  

Total capitalization(2)

    21,346,009     3,403,056     21,346,009     3,403,056     30,442,682     4,853,280  

Notes:

(1)
The pro forma as adjusted information discussed above is illustrative only. Our additional paid-in capital, total shareholders' equity and total capitalization following the completion of this offering are subject to adjustment based on the actual initial public offering price and other terms of this offering determined at pricing.

4


(2)
Assuming the number of ADSs offered by us as set forth on the cover page of this prospectus remains the same, and after deduction of underwriting discounts and commissions and the estimated offering expenses payable by us, a US$1.00 increase (decrease) in the assumed initial public offering price of US$17.50 per ADS, the midpoint of the range set forth on the cover page of this prospectus, would increase (decrease) each of additional paid-in capital, total shareholder's (deficit)/equity, and total capitalization by US$85.6 million.

Management's Discussion and Analysis of Financial Condition and Results of Operations

(10)
Amend the last sentence of the second paragraph on page 81 as follows:
(11)
Amend the last sentence of the fourth paragraph on page 81 as follows:
(12)
Amend the second sentence of the last paragraph on page 82 as follows:
(13)
Add the following on pages 103 and 104:

Business

(14)
Amend the last sentence of the first paragraph on page 109 as follows:
(15)
Amend the last sentence of the third paragraph on page 109 as follows:
(16)
Amend the last sentence of the fourth paragraph on page 109 as follows:
(17)
Amend the last sentence of the second full paragraph on page 110 as follows:

5


(18)
Amend the last sentence of the fifth full paragraph on page 110 as follows:
(19)
Amend the last two sentences of the third full paragraph on page 113 as follows:
(20)
Amend the last sentence of the second paragraph on page 114 as follows:
(21)
Amend the last sentence of the fifth paragraph on page 116 as follows:

Underwriting

(22)
Add the following on pages 188 and 189:

Notes to the Condensed Consolidated Financial Statements

(23)
Add the following sentence at the end of note 14 on page F-72:

6




QuickLinks

Pinduoduo Inc.